Tyler-Stone Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$246K Sell
881
-2
-0.2% -$567 0.04% 298
2025
Q1
$275K Sell
883
-235
-21% -$69.4K 0.05% 272
2024
Q4
$291K Buy
1,118
+159
+17% +$47.2K 0.05% 256
2024
Q3
$309K Buy
959
+591
+161% +$193K 0.06% 240
2024
Q2
$115K Hold
368
0.05% 263
2024
Q1
$105K Hold
368
0.05% 266
2023
Q4
$106K Buy
368
+38
+12% +$10.4K 0.05% 259
2023
Q3
$89K Hold
330
0.05% 266
2023
Q2
$73K Buy
+330
New +$76.6K 0.04% 290
2022
Q4
$87K Hold
330
0.06% 254
2022
Q3
$74K Sell
330
-58
-15% -$14.1K 0.06% 256
2022
Q2
$94K Buy
388
+6
+2% +$1.47K 0.06% 244
2022
Q1
$92K Sell
382
-485
-56% -$111K 0.05% 261
2021
Q4
$195K Buy
+867
New +$183K 0.1% 182

Other funds holding AMGN

Tyler-Stone Wealth Management's AMGN Position: Q2 2025 in Review

Tyler-Stone Wealth Management reduced its Amgen (AMGN) stake by 0.23% in Q2 2025, selling an estimated $567 and leaving 881 shares worth $246K. The position accounts for 0.04% of the portfolio, ranked #298.

Tyler-Stone Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 14 quarters since. The position peaked at $309K in Q3 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Tyler-Stone Wealth Management held 881 shares of Amgen worth $246K as of Q2 2025.
  • Tyler-Stone Wealth Management sold 2 Amgen shares in Q2 2025, an estimated $567.
  • Amgen made up 0.04% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #298 holding.
  • Tyler-Stone Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 14 quarters since.
  • Tyler-Stone Wealth Management's Amgen position peaked at $309K in Q3 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.